{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:28:34Z","timestamp":1794216514745,"version":"4.8.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jneuroim.2026.579099","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:51:39Z","timestamp":1789253499000},"page":"579099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Microbiome-gut-brain axis modulation for the management of Parkinson's disease: Emerging mechanisms and translational insights"],"prefix":"10.1016","volume":"421","author":[{"given":"Madhavi","family":"Porwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabha","family":"Malviya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phool","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathvik Belagodu","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javedh","family":"Shareef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya Bajpai","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Arockiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579099_bb0005","first-page":"1","article-title":"Unveiling butyrate as a Parkinson\u2019s disease therapy","author":"Abreu","year":"2025","journal-title":"Neurosci. Bull."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579099_bb0010","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0015","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.002117","article-title":"SCFAs\u2019 pleiotropic role in pathogenesis and salutogenesis: mechanisms in exacerbation and regulation of inflammation and fibrosis from gut to host","volume":"75","author":"Ahmad","year":"2026","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579099_bb0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2004.6.3\/galexander","article-title":"Biology of Parkinson\u2019s disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","volume":"6","author":"Alexander","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tem.2021.11.005","article-title":"Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson\u2019s disease","volume":"33","author":"Anis","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12967-025-07428-9","article-title":"Dietary interventions and the gut microbiota: a systematic literature review of 80 controlled clinical trials","volume":"24","author":"Aslam","year":"2026","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12915-020-00775-7","article-title":"Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions","volume":"18","author":"Baldini","year":"2020","journal-title":"BMC Biol."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579099_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107742","article-title":"Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: mutations, propagation, aggregation, and the formation of inclusions","volume":"300","author":"Bayati","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","article-title":"Fecal microbiota transplantation and emerging applications","volume":"9","author":"Borody","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"263","key":"10.1016\/j.jneuroim.2026.579099_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0070","article-title":"Vagus nerve as modulator of the brain\u2013gut axis in psychiatric and inflammatory disorders","volume":"9","author":"Breit","year":"2018","journal-title":"Front. Psychol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579099_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrm2873","article-title":"Prion-like transmission of protein aggregates in neurodegenerative diseases","volume":"11","author":"Brundin","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579099_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0085","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann. Gastroenterol. Q. Publ. Hellenic Soc. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579099_bb0090","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","article-title":"Gastrointestinal manifestations in Parkinson\u2019s disease: prevalence and occurrence before motor symptoms","volume":"260","author":"Cersosimo","year":"2013","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579099_bb0095","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1177\/1877718X251328567","article-title":"Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson\u2019s disease manifestation","volume":"15","author":"Chai","year":"2025","journal-title":"J. Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579099_bb0100","doi-asserted-by":"crossref","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s43556-025-00307-1","article-title":"Microbiota\u2013gut\u2013brain axis in neurodegenerative diseases: molecular mechanisms and therapeutic targets","volume":"6","author":"Chen","year":"2025","journal-title":"Mol. Biomed."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579099_bb0110","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1210\/me.2014-1108","article-title":"Minireview: gut microbiota: the neglected endocrine organ","volume":"28","author":"Clarke","year":"2014","journal-title":"Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579099_bb0115","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579099_bb0120","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","article-title":"The microbiota-gut-brain axis","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol. Rev."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579099_bb0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579099_bb0130","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579099_bb0135","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1136\/gutjnl-2015-309957","article-title":"High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome","volume":"65","author":"De Filippis","year":"2016","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579099_bb0140","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson\u2019s disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"issue":"13","key":"10.1016\/j.jneuroim.2026.579099_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137379","article-title":"The role of short chain fatty acids in inflammation and body health","volume":"25","author":"Du","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579099_bb0150","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"14","key":"10.1016\/j.jneuroim.2026.579099_bb0155","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences","volume":"31","author":"Exner","year":"2012","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-025-02393-8","article-title":"Interactions between gut microbiota and Parkinson\u2019s disease: the role of tryptophan metabolism","volume":"23","author":"Fan","year":"2025","journal-title":"Cell Commun. Signal"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579099_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.4476","article-title":"Interactions between the microbiota, immune and nervous systems in health and disease","volume":"20","author":"Fung","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579099_bb0175","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579099_bb0180","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tim.2017.11.002","article-title":"Human gut microbiome: function matters","volume":"26","author":"Heintz-Buschart","year":"2018","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1177\/1756283X12459294","article-title":"Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation","volume":"6","author":"Hemarajata","year":"2013","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579099_bb0190","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0195","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-016-0002-0","article-title":"The gut-brain axis: is intestinal inflammation a silent driver of Parkinson\u2019s disease pathogenesis?","volume":"3","author":"Houser","year":"2017","journal-title":"NPJ Parkinsons Dis."},{"issue":"26","key":"10.1016\/j.jneuroim.2026.579099_bb0205","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016163","article-title":"Fecal microbiota transplantation to treat Parkinson's disease with constipation: a case report","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05184-7","article-title":"Gut microbiota associations with common diseases and prescription medications in a population-based cohort","volume":"9","author":"Jackson","year":"2018","journal-title":"Nat. Commun."},{"issue":"9996","key":"10.1016\/j.jneuroim.2026.579099_bb0215","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.jneuroim.2026.579099_bb0220","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1111\/febs.13412","article-title":"The dynamic blood\u2013brain barrier","volume":"282","author":"Keaney","year":"2015","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579099_bb0225","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3390\/biomedicines12081738","article-title":"The gut microbiome as a catalyst and emerging therapeutic target for Parkinson\u2019s disease: a comprehensive update","volume":"12","author":"Kerstens","year":"2024","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579099_bb0230","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson\u2019s disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579099_bb0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2026.579099_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.782082","article-title":"The gut\u2013brain axis and its relation to Parkinson\u2019s disease: a review","volume":"13","author":"Klann","year":"2022","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579099_bb0245","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1111\/ene.15671","article-title":"Gut microbiota dysbiosis in Parkinson disease: a systematic review and pooled analysis","volume":"30","author":"Kleine Bardenhorst","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0250","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/bs.irn.2017.05.027","article-title":"The gut and nonmotor symptoms in Parkinson\u2019s disease","volume":"134","author":"Klingelhoefer","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0255","series-title":"Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis","first-page":"3","author":"Kouli","year":"2018"},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579099_bb0260","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1002\/mds.70047","article-title":"Effects of a four-strain probiotic on gut microbiota, inflammation, and symptoms in Parkinson\u2019s disease: a randomized clinical trial","volume":"40","author":"Leta","year":"2025","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579099_bb0265","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","article-title":"Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features","volume":"60","author":"Li","year":"2017","journal-title":"Sci. China Life Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0270","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s12035-021-02657-7","article-title":"Review of metabolomics-based biomarker research for Parkinson\u2019s disease","volume":"59","author":"Li","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"12","key":"10.1016\/j.jneuroim.2026.579099_bb0275","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00415-025-13546-7","article-title":"Cerebrospinal fluid biomarkers for diagnosis of Parkinson\u2019s disease: a systematic review and network meta-analysis","volume":"272","author":"Li","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0280","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2018.01.010","article-title":"Parkinson\u2019s disease from the gut","volume":"1693","author":"Liddle","year":"2018","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease","volume":"16","author":"Lin","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0290","article-title":"Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6109","key":"10.1016\/j.jneuroim.2026.579099_bb0295","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2026.579099_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108475","article-title":"Research progress on the role of oxidative stress in the pathogenesis of vascular dementia and its treatment","volume":"34","author":"Lv","year":"2025","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.579099_bb0305","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3390\/nu9091021","article-title":"Effects of probiotics, prebiotics, and synbiotics on human health","volume":"9","author":"Markowiak","year":"2017","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579099_bb0310","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4103\/1673-5374.308089","article-title":"Short-chain fatty acids in the context of Parkinson\u2019s disease","volume":"16","author":"Metzdorf","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.594150","article-title":"Role of metabolic endotoxemia in systemic inflammation and potential interventions","volume":"11","author":"Mohammad","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579099_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/nu18030372","article-title":"Prebiotics and gut health: mechanisms, clinical evidence, and future directions","volume":"18","author":"Monteiro","year":"2026","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0325","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exper. Neurobiol."},{"issue":"7","key":"10.1016\/j.jneuroim.2026.579099_bb0330","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11011-021-00808-2","article-title":"Gut brain axis: an insight into microbiota role in Parkinson\u2019s disease","volume":"36","author":"Moustafa","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13024-024-00766-0","article-title":"Gut-first Parkinson\u2019s disease is encoded by gut dysbiome","volume":"19","author":"Munoz-Pinto","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0340","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-022-00367-z","article-title":"Inflammatory microbes and genes as potential biomarkers of Parkinson\u2019s disease","volume":"8","author":"Nie","year":"2022","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579099_bb0345","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13138-5","article-title":"The gut\u2013brain axis in early Parkinson\u2019s disease: from prodrome to prevention","volume":"272","author":"Oliver","year":"2025","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0350","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","article-title":"Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health","volume":"11","author":"Parker","year":"2020","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0355","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-13545-8","article-title":"The role of the gut microbiome in the progression of Parkinson\u2019s disease: a systematic review of patient cohorts","volume":"273","author":"Peters","year":"2026","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jneuroim.2026.579099_bb0365","first-page":"1","article-title":"Gut ecosystem dysfunction in Parkinson\u2019s disease: deciphering faecal metabolome-metagenome links for novel diagnostic panels","volume":"12","author":"Qian","year":"2026","journal-title":"NPJ Park. Dis."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0370","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10068-023-01414-x","article-title":"The functional roles of short chain fatty acids as postbiotics in human gut: future perspectives","volume":"33","author":"Ragavan","year":"2023","journal-title":"Food Sci. Biotechnol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579099_bb0375","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00037","article-title":"Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease","volume":"8","author":"Rietdijk","year":"2017","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"npj Parkinsons Dis."},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579099_bb0390","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579099_bb0395","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.jneuroim.2026.579099_bb0400","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jamaneurol.2024.2305","article-title":"Fecal microbiota transplantation for treatment of Parkinson disease: a randomized clinical trial","volume":"81","author":"Scheperjans","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micres.2025.128317","article-title":"Akkermansia muciniphila: a key player in gut microbiota-based disease modulation","volume":"301","author":"Shaheen","year":"2025","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134516","article-title":"Altered gut microbiota and intestinal permeability in Parkinson\u2019s disease: pathological highlight to management","volume":"712","author":"Sharma","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105840","article-title":"The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders","volume":"172","author":"Soca\u0142a","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6645","key":"10.1016\/j.jneuroim.2026.579099_bb0420","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2026.579099_bb0425","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitter modulation by the gut microbiota","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0430","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2018.04.004","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s disease","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing Res. Rev."},{"issue":"15","key":"10.1016\/j.jneuroim.2026.579099_bb0435","doi-asserted-by":"crossref","first-page":"10736","DOI":"10.1074\/jbc.R112.410530","article-title":"Calcium, bioenergetics, and neuronal vulnerability in Parkinson\u2019s disease","volume":"288","author":"Surmeier","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0440","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579099_bb0445","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of P arkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579099_bb0450","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/ana.24448","article-title":"Vagotomy and subsequent risk of Parkinson\u2019s disease","volume":"78","author":"Svensson","year":"2015","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579099_bb0455","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.clnu.2018.05.018","article-title":"Clinical and metabolic response to probiotic administration in people with Parkinson\u2019s disease: a randomized, double-blind, placebo-controlled trial","volume":"38","author":"Tamtaji","year":"2019","journal-title":"Clin. Nutr."},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579099_bb0460","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","article-title":"The microbiome-gut-brain axis in Parkinson disease\u2014from basic research to the clinic","volume":"18","author":"Tan","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"15","key":"10.1016\/j.jneuroim.2026.579099_bb0465","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3390\/cells14151161","article-title":"Parkinson\u2019s disease: bridging gaps, building biomarkers, and reimagining clinical translation","volume":"14","author":"Tanaka","year":"2025","journal-title":"Cells"},{"issue":"s2","key":"10.1016\/j.jneuroim.2026.579099_bb0470","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.3233\/JPD-191707","article-title":"The intestinal barrier in Parkinson\u2019s disease: current state of knowledge","volume":"9","author":"van IJzendoorn","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579099_bb0475","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mSystems.00561-20","article-title":"Gut microbiota and metabolome alterations associated with Parkinson\u2019s disease","volume":"5","author":"Vascellari","year":"2020","journal-title":"Msystems"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0480","article-title":"Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson\u2019s disease","volume":"13","author":"Villette","year":"2025","journal-title":"Microbiome"},{"issue":"03","key":"10.1016\/j.jneuroim.2026.579099_bb0485","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/CM9.0000000000003318","article-title":"Gut microbiota and Parkinson\u2019s disease","volume":"138","author":"Wang","year":"2025","journal-title":"Chin. Med. J."},{"issue":"20","key":"10.1016\/j.jneuroim.2026.579099_bb0490","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s00018-017-2550-9","article-title":"Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis","volume":"74","author":"Westfall","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"35","key":"10.1016\/j.jneuroim.2026.579099_bb0495","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022035","article-title":"Fecal microbiota transplantation therapy for Parkinson's disease: a preliminary study","volume":"99","author":"Xue","year":"2020","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579099_bb0500","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","article-title":"Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis","volume":"161","author":"Yano","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2026.579099_bb0505","series-title":"Pharmacological treatment of Parkinson\u2019s disease","first-page":"129","author":"Zahoor","year":"2018"},{"issue":"11","key":"10.1016\/j.jneuroim.2026.579099_bb0510","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrn1537","article-title":"Iron, brain ageing and neurodegenerative disorders","volume":"5","author":"Zecca","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0515","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0520","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson\u2019s disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579099_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-024-00802-2","article-title":"Microbial biomarker discovery in Parkinson\u2019s disease through a network-based approach","volume":"10","author":"Zhao","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.jneuroim.2026.579099_bb0530","article-title":"Gut microbiota: a novel therapeutic target for Parkinson\u2019s disease","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826002481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:16:21Z","timestamp":1794215781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826002481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":106,"alternative-id":["S0165572826002481"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579099","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiome-gut-brain axis modulation for the management of Parkinson's disease: Emerging mechanisms and translational insights","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"579099"}}